RCKT
Price
$5.11
Change
-$0.45 (-8.09%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
591.79M
37 days until earnings call
RGNX
Price
$6.29
Change
-$0.38 (-5.70%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
334.07M
25 days until earnings call
Ad is loading...

RCKT vs RGNX

Header iconRCKT vs RGNX Comparison
Open Charts RCKT vs RGNXBanner chart's image
Rocket Pharmaceuticals
Price$5.11
Change-$0.45 (-8.09%)
Volume$62.22K
Capitalization591.79M
REGENXBIO
Price$6.29
Change-$0.38 (-5.70%)
Volume$21.16K
Capitalization334.07M
RCKT vs RGNX Comparison Chart
Loading...
Annualized Return-0%
VIEW DETAILSVIEW DETAILS
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCKT vs. RGNX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCKT is a Hold and RGNX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (RCKT: $5.56 vs. RGNX: $6.67)
Brand notoriety: RCKT and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RCKT: 245% vs. RGNX: 94%
Market capitalization -- RCKT: $591.79M vs. RGNX: $334.07M
RCKT [@Biotechnology] is valued at $591.79M. RGNX’s [@Biotechnology] market capitalization is $334.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCKT’s FA Score shows that 1 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • RCKT’s FA Score: 1 green, 4 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than RCKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCKT’s TA Score shows that 4 TA indicator(s) are bullish while RGNX’s TA Score has 3 bullish TA indicator(s).

  • RCKT’s TA Score: 4 bullish, 4 bearish.
  • RGNX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than RGNX.

Price Growth

RCKT (@Biotechnology) experienced а -29.44% price change this week, while RGNX (@Biotechnology) price change was -15.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.75%. For the same industry, the average monthly price growth was -16.58%, and the average quarterly price growth was -18.37%.

Reported Earning Dates

RCKT is expected to report earnings on May 12, 2025.

RGNX is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-10.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($592M) has a higher market cap than RGNX($334M). RGNX YTD gains are higher at: -13.713 vs. RCKT (-55.768). RGNX has higher annual earnings (EBITDA): -198.23M vs. RCKT (-247.48M). RCKT has more cash in the bank: 372M vs. RGNX (235M). RCKT has less debt than RGNX: RCKT (25.5M) vs RGNX (82M). RGNX has higher revenues than RCKT: RGNX (83.3M) vs RCKT (0).
RCKTRGNXRCKT / RGNX
Capitalization592M334M177%
EBITDA-247.48M-198.23M125%
Gain YTD-55.768-13.713407%
P/E RatioN/AN/A-
Revenue083.3M-
Total Cash372M235M158%
Total Debt25.5M82M31%
FUNDAMENTALS RATINGS
RCKT vs RGNX: Fundamental Ratings
RCKT
RGNX
OUTLOOK RATING
1..100
470
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
76
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
9563
P/E GROWTH RATING
1..100
10018
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RCKT's Valuation (28) in the Biotechnology industry is somewhat better than the same rating for RGNX (76). This means that RCKT’s stock grew somewhat faster than RGNX’s over the last 12 months.

RCKT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RGNX (100). This means that RCKT’s stock grew similarly to RGNX’s over the last 12 months.

RCKT's SMR Rating (97) in the Biotechnology industry is in the same range as RGNX (98). This means that RCKT’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's Price Growth Rating (63) in the Biotechnology industry is in the same range as RCKT (95). This means that RGNX’s stock grew similarly to RCKT’s over the last 12 months.

RGNX's P/E Growth Rating (18) in the Biotechnology industry is significantly better than the same rating for RCKT (100). This means that RGNX’s stock grew significantly faster than RCKT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCKTRGNX
RSI
ODDS (%)
Bullish Trend 5 days ago
73%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 5 days ago
80%
Momentum
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
80%
MACD
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
85%
Bullish Trend 5 days ago
74%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 18 days ago
75%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
73%
Bearish Trend 5 days ago
85%
Aroon
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
85%
View a ticker or compare two or three
Annualized Return-0%
VIEW DETAILSVIEW DETAILS
Ad is loading...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with NTLA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
-11.75%
NTLA - RCKT
56%
Loosely correlated
-5.62%
RGNX - RCKT
54%
Loosely correlated
-5.39%
CRSP - RCKT
52%
Loosely correlated
-4.47%
ETNB - RCKT
51%
Loosely correlated
-4.59%
FATE - RCKT
50%
Loosely correlated
-11.69%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with RCKT. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-5.39%
RCKT - RGNX
54%
Loosely correlated
-11.75%
DNLI - RGNX
53%
Loosely correlated
-6.91%
NTLA - RGNX
50%
Loosely correlated
-5.62%
ARWR - RGNX
48%
Loosely correlated
-4.96%
FATE - RGNX
47%
Loosely correlated
-11.69%
More